LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 Selumetinib
0.37
uM
LJP6
 0.9800 0.0276 0.9710 0.0394
BT-20 Sirolimus
0.37
uM
LJP6
 0.6222 0.0230 0.4528 0.0311
BT-20 Sorafenib
0.37
uM
LJP6
 0.8654 0.0292 0.8064 0.0389
BT-20 SU11274
0.37
uM
LJP5
 1.0195 0.0157 1.0284 0.0227
BT-20 Fedratinib
0.37
uM
LJP5
 0.9591 0.0117 0.9413 0.0159
BT-20 TGX221
0.37
uM
LJP5
 1.0218 0.0099 1.0322 0.0153
BT-20 Torin1
0.37
uM
LJP6
 0.3168 0.0271 0.0113 0.0228
BT-20 Torin2
0.37
uM
LJP5
 0.2458 0.0224 -0.0926 0.0326
BT-20 Tozasertib
0.37
uM
LJP5
 0.2995 0.0145 -0.0160 0.0417
BT-20 Trametinib
0.37
uM
LJP5
 0.8022 0.0278 0.7150 0.0352
BT-20 TWS119
0.37
uM
LJP5
 0.9913 0.0258 0.9889 0.0374
BT-20 Vemurafenib
0.37
uM
LJP5
 0.9861 0.0179 0.9804 0.0253
BT-20 Withaferin A
0.37
uM
LJP5
 0.7818 0.0429 0.6829 0.0644
BT-20 Withaferin A
0.37
uM
LJP6
 0.7586 0.0817 0.6540 0.1121
BT-20 WYE-125132
0.37
uM
LJP6
 0.4245 0.0390 0.1679 0.0427
BT-20 WZ3105
0.37
uM
LJP5
 0.2844 0.0379 -0.0391 0.0751
BT-20 XMD11-50
0.37
uM
LJP6
 0.8245 0.0774 0.7500 0.1083
BT-20 Y39983
0.37
uM
LJP6
 0.9485 0.0427 0.9277 0.0618
BT-20 YM 201636
0.37
uM
LJP5
 0.9634 0.0154 0.9473 0.0218
BT-20 ZSTK474
0.37
uM
LJP6
 0.6890 0.1223 0.5563 0.1710
BT-20 Afatinib
1.11
uM
LJP6
 0.8758 0.0257 0.8201 0.0367
BT-20 Sigma A6730
1.11
uM
LJP5
 0.8895 0.0040 0.8398 0.0072
BT-20 Alvocidib
1.11
uM
LJP6
 0.1536 0.0327 -0.2282 0.0701
BT-20 AT-7519
1.11
uM
LJP6
 0.2129 0.0323 -0.1402 0.0463
BT-20 AZD 5438
1.11
uM
LJP6
 0.3470 0.0485 0.0564 0.0524